Les publications

Page en cours de mise à jour... Retrouvez ici les publications des équipes de recherche du CGO

384 publications
Année de publication :
Réseaux :

Feasibility and safety of tailored dosing schedule for eculizumab based on therapeutic drug monitoring: lessons from…

Eculizumab is an anti-C5 monoclonal antibody approved for rare diseases including atypical haemolytic-uraemic syndrome. The maintenance phase dosing regimen is identical for all adult patients: 1200 mg every 2 weeks.

  • Ref: Br J Clin Pharmacol. 2020 Oct 28.
  • Année de publication : 2020
  • Auteurs : Passot C, Sberro-Soussan R, Bertrand D, Caillard S, Schvartz B, Domenger C, Contin-Bordes C, Paintaud G, Halimi JM, Ternant D, Gatault P. Br
  • Réseaux : Réseaux: non classé
Lire la publication

Three-Dimensional Culture Systems in Gastric Cancer Research.

Gastric cancer (GC), which includes cancer of the esophagus, the oesophagogastric junction, and the stomach fundus, is highly deadly with strong regional influence, Asia being the most affected.

  • Ref: Cancers (Basel). 2020 Sep 29;12(10):2800.
  • Année de publication : 2020
  • Auteurs : Alzeeb G, Metges JP, Corcos L, Le Jossic-Corcos C.
  • Réseaux : Réseaux: « Niches et Epigénétique des Tumeurs »
Lire la publication

ROS Overproduction Sensitises Myeloma Cells to Bortezomib-Induced Apoptosis and Alleviates Tumour Microenvironment-Mediated Cell Resistance.

Multiple myeloma (MM) is a plasma cell neoplasm that remains incurable due to innate or acquired resistance. Although MM cells produce high intracellular levels of reactive oxygen species (ROS), we hypothesised that they could remain sensitive to ROS unbalance.

  • Ref: Cells. 2020 Oct 26;9(11):E2357.
  • Année de publication : 2020
  • Auteurs : Caillot M, Zylbersztejn F, Maitre E, Bourgeais J, Hérault O, Sola B.
  • Réseaux : Réseaux: « Niches et Epigénétique des Tumeurs »
Lire la publication

4C3 Human Monoclonal Antibody: A Proof of Concept for Non-pathogenic Proteinase 3 Anti-neutrophil Cytoplasmic Antibodies in…

Granulomatosis with polyangiitis (GPA) is a severe autoimmune vasculitis associated with the presence of anti-neutrophil cytoplasmic antibodies (ANCA) mainly targeting proteinase 3 (PR3), a neutrophilic serine proteinase.

  • Ref: Front Immunol. 2020 Sep 25;11:573040.
  • Année de publication : 2020
  • Auteurs : Granel J, Lemoine R, Morello E, Gallais Y, Mariot J, Drapeau M, Musnier A, Poupon A, Pugnière M, Seren S, Nouar D, Gouilleux-Gruart V, Watier H, Korkmaz B, Hoarau C.
  • Réseaux : Réseaux: « Immunothérapies »
Lire la publication

Repurposing of Acriflavine to target Chronic Myeloid Leukemia treatment.

Drug repurposing has lately received increasing interest in several diseases especially in cancers, due to its advantages in facilitating the development of new therapeutic strategies, by adopting a cost-friendly approach and avoiding the strict Food and Drug Administration (FDA) regulations.

  • Ref: Curr Med Chem. 2020 Sep 8.
  • Année de publication : 2020
  • Auteurs : Nehme R, Hallal R, El Dor M, Kobeissy F, Gouilleux F, Mazurier F, Zibara K.
  • Réseaux : Réseaux: non classé
Lire la publication

Horizontal meta-analysis identifies common deregulated genes across AML subgroups providing a robust prognostic signature.

Advances in transcriptomics have improved our understanding of leukemic development and helped to enhance the stratification of patients.

  • Ref: Blood Adv. 2020 Oct 27;4(20):5322-5335.
  • Année de publication : 2020
  • Auteurs : Nehme A, Dakik H, Picou F, Cheok M, Preudhomme C, Dombret H, Lambert J, Gyan E, Pigneux A, Récher C, Béné MC, Gouilleux F, Zibara K, Herault O, Mazurier F.
  • Réseaux : Réseaux: « Niches et Epigénétique des Tumeurs »
Lire la publication

The evolving field of Dermato-oncology and the role of dermatologists: Position Paper of the EADO, EADV…

The incidence of skin cancers has been increasing steadily over the last decades. Although there have been significant breakthroughs in the management of skin cancers with the introduction of novel diagnostic tools and innovative therapies, skin cancer mortality, morbidity and costs heavily burden the society.

  • Ref: J Eur Acad Dermatol Venereol. 2020 Oct;34(10):2183-2197.
  • Année de publication : 2020
  • Auteurs : Garbe C, Peris K, Soura E, Forsea AM, Hauschild A, Arenbergerova M, Bylaite M, Del Marmol V, Bataille V, Samimi M, Gandini S, Saiag P, Eigentler TK, Lallas A, Zalaudek I, Lebbe C, Grob JJ, Hoeller C, Robert C, Dréno B, Arenberger P, Kandolf-Sekulovic L, Kaufmann R, Malvehy J, Puig S, Leiter U, Ribero S, Papadavid E, Quaglino P, Bagot M, John SM, Richard MA, Trakatelli M, Salavastru C, Borradori L, Marinovic B, Enk A, Pincelli C, Ioannides D, Paul C, Stratigos AJ.
  • Réseaux : Réseaux: non classé
Lire la publication